https://www.selleckchem.com/pr....oducts/8-bromo-camp.
8 min/wk.; 95% CI = -43 to 61; p = 0.74). The reduction in MVPA in the control group over the first 12-weeks was also maintained at 24-weeks (5.4 min/wk.; 95% CI = -3.6 to 4.6; p = 0.8. Secondary outcomes did not differ between groups at 24-weeks. Our results suggest distance-based interventions using wearable technology produce increases in MVPA that endure at least 12-weeks after the intervention is completed. Our results suggest distance-based interventions using wearable technology produce increases in MVPA that endure at lea